Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Cutaneous melanoma in patients in treatment with biological therapy: review of the literature and case report.

Manganoni AM, Zane C, Pavoni L, Farisoglio C, Sereni E, Calzavara-Pinton P.

Dermatol Online J. 2011 Aug 15;17(8):12. Review.

PMID:
21906492
2.

Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.

Buchbinder R, Barber M, Heuzenroeder L, Wluka AE, Giles G, Hall S, Harkness A, Lewis D, Littlejohn G, Miller MH, Ryan PF, Jolley D.

Arthritis Rheum. 2008 Jun 15;59(6):794-9. doi: 10.1002/art.23716.

3.

Multiple malignant melanomas in a patient with RA treated with methotrexate.

Potter T, Hardwick N, Mulherin D.

J Rheumatol. 1998 Nov;25(11):2282-3. No abstract available.

PMID:
9818680
4.

Development of two primary malignant melanomas after treatment with adalimumab: a case report and review of the possible link between biological therapy with TNF-alpha antagonists and melanocytic proliferation.

Katoulis AC, Kanelleas A, Zambacos G, Panayiotides I, Stavrianeas NG.

Dermatology. 2010 Aug;221(1):9-12. doi: 10.1159/000300136. Epub 2010 May 13. Review.

PMID:
20484878
5.
6.

Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.

Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A.

Int J Rheum Dis. 2012 Jun;15(3):330-5. doi: 10.1111/j.1756-185X.2012.01715.x. Epub 2012 Feb 13.

PMID:
22709496
7.

[Cutaneous pseudolymphoma during treatment of rheumatoid polyarthritis with low-dose methotrexate].

Delaporte E, Catteau B, Cardon T, Flipo RM, Lecomte-Houcke M, Piette F, Delcambre B, Bergoend H.

Ann Dermatol Venereol. 1995;122(8):521-5. Review. French.

PMID:
8572492
8.

Primary cutaneous melanoma: a complication of infliximab treatment?

Khan I, Rahman L, McKenna DB.

Clin Exp Dermatol. 2009 Jun;34(4):524-6. doi: 10.1111/j.1365-2230.2008.02970.x. Epub 2009 Jan 13. No abstract available.

PMID:
19196307
10.

Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis.

Fam AG, Perez-Ordonez B, Imrie K.

J Rheumatol. 2000 Jun;27(6):1546-9.

PMID:
10852288
12.

Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate.

Nakashima C, Tanioka M, Takahashi K, Miyachi Y.

Clin Exp Dermatol. 2008 Jul;33(4):437-9. doi: 10.1111/j.1365-2230.2007.02683.x. Epub 2008 May 15.

PMID:
18485021
13.

Association of methotrexate, rheumatoid arthritis, and melanoma in 2 patients.

Jeannou J, Goupille P, Valat JP.

J Rheumatol. 1997 Jul;24(7):1444-5. No abstract available.

PMID:
9228153
14.
15.

Pembrolizumab-associated inflammatory myopathy.

Gandiga PC, Wang AR, Gonzalez-Rivera T, Sreih AG.

Rheumatology (Oxford). 2018 Feb 1;57(2):397-398. doi: 10.1093/rheumatology/kex346. No abstract available.

PMID:
29088490
16.

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.

Weisman MH, Moreland LW, Furst DE, Weinblatt ME, Keystone EC, Paulus HE, Teoh LS, Velagapudi RB, Noertersheuser PA, Granneman GR, Fischkoff SA, Chartash EK.

Clin Ther. 2003 Jun;25(6):1700-21.

PMID:
12860493
17.

Fatal varicella-zoster virus vasculopathy associated with adalimumab therapy.

Baek W, Lee SG, Kim YS, Kim JH, Jun JB, Kim HY.

Arch Neurol. 2012 Sep;69(9):1193-6. doi: 10.1001/archneurol.2011.3741.

PMID:
22732856
18.

Metastatic melanoma in a young woman treated with TNF-α inhibitor for psoriatic arthritis: a case report.

Marasini B, Cozzaglio L, Belloli L, Massarotti M, Ughi N, Pedrazzoli P.

Curr Drug Saf. 2011 Sep 1;6(4):275-6.

PMID:
22129323
19.

[Multiple primary malignant melanomas in psoriasis vulgaris under long-term methotrexate therapy].

Wemmer U.

Z Hautkr. 1984 May 15;59(10):665-8. German. No abstract available.

PMID:
6429960
20.

Skin reaction to adalimumab.

Beuthien W, Mellinghoff HU, von Kempis J.

Arthritis Rheum. 2004 May;50(5):1690-2.

Supplemental Content

Support Center